A vaccine composition comprising a saponin and an immunostimulatory oligonucleotide and a tumor associated antigen.
PK141229AUndetermined Publication Date: 2011-08-30GLAXOSMITHKLINE BIOLOGICALS SA
0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- GLAXOSMITHKLINE BIOLOGICALS SA
- Publication Date
- 2011-08-30
Abstract
A vaccine composition comprising a saponin and an immunostimulatory oligonucleotide and a tumor associated antigen, tumor rejection antigen or antigens associated with tumor support mechanisms, use for prophylaxis or the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art